Oncology Nutrition Market Analysis 2026

Current scenario of the oncology nutrition market 

Key drivers of the Oncology Nutrition  market

• The increasing prevalence of cancer is driving market expansion.

The World Health Organisation (WHO) ranks cancer as the world's second largest cause of death. According to WHO figures, around 25% of cancer patients die as a result of malnutrition caused by sickness or anticancer medication. In 2020, there were an anticipated 18.1 million cancer cases worldwide. There were 9.3 million male and 8.8 million female cases. In 2020, breast and lung cancers accounted for 12.5% and 12.2% of all new cases diagnosed globally, respectively.
In 2020, there were around 1.9 million new cases of colorectal cancer, accounting for 10.7% of all new cases. Lung cancer was the most common cancer in men globally in 2020, accounting for 15.4% of all new cases. Lung, prostate, and colorectal cancer accounted for 41.9% of all cancers (excluding non-melanoma skin cancer). Stomach and liver cancers each accounted for more than 5%. In 2020, breast cancer accounted for 25.8% of all new cancer cases diagnosed in women globally. Breast, colorectal, and lung cancers made for 44.5% of all cancer cases (excluding non-melanoma skin cancer). Cervical cancer was the fourth most common cancer among women in 2020, accounting for 6.9% of all newly diagnosed cases.
https://www.who.int/news-room/fact-sheets/detail/cancer

• Increasingly Ageing Population to Drive Market Expansion

Over 1.5 billion individuals will be elderly in the world in 2050, having doubled in the previous three decades. Between 2019 and 2050, the number of elderly people is expected to rise throughout all regions. However, Eastern and Southeast Asia will see the biggest increase.. The World Health Organisation (WHO) projects that by 2050, the proportion of elderly people worldwide will almost double, from 12% to 22%. The market has enormous potential and is very profitable.
Furthermore, the growing older population is predicted to drive the industry's growth in the near future because they are more likely to develop cancer. According to WHO figures, the global population aged 60 and above is expected to exceed 2 billion by 2050. Individuals 65 and older account for almost 60% of all malignancies. Furthermore, this stage accounts for roughly 70% of all cancer-related deaths.
https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~:text=By%202050%2C%20the%20world's%20population,2050%20to%20reach%20426%20million.

Constraints for the global Oncology Nutrition  market

• High Cost and complications of Oncology Nutrition Products

The high cost of oncology nutrition products is a major barrier to growth in the global industry. Cancer patients may require specialised goods with precise nutrient formulations to suit their dietary needs. Specialised goods are more expensive than ordinary nutritional supplements due to increased costs for research, manufacturing, and quality control. Personalised nutrition planning and counselling services increase the expense of oncology nutrition. The high cost of these products may limit their accessibility and affordability, especially for lower-income individuals or patients.
Tube feeding difficulties are projected to slow the oncology nutrition market's development pace. Constipation, dehydration, diarrhoea, skin problems, inadvertent intestine rips, and stomach infection are among potential risks of using a feeding tube. Tube feeding difficulties can have an impact on both the patient's health and the cancer nutrition industry.

Opportunities for the global Oncology Nutrition  market

• Growing Awareness of Oncology Nutrition will fuel future growth.

The oncology nutrition sector is gaining traction as more private and public organisations focus on raising awareness. The Nutritional Oncology Research Institute (NORI) Nutraceuticals offers high-quality nutritional supplements and specialist nutraceuticals for clinical oncology. NORI combines the power of nutrition with a few extremely natural substances to help halt cancer progression and possibly reverse it.The Academy of Nutrition and Dietetics supports the Oncology Nutrition Dietetic Practice Group through publication and consultancy, which includes advocacy and educational research as an oncology nutrition pioneer with experts.
https://www.oncologynutrition.org/about-us
MNI, the Medical Nutrition International Industry association, represents companies that offer nutritional therapy solutions such as Oral Nutritional Supplements (ONS), Enteral Tube Feeding (enteral nutrition via the gastrointestinal tract), and Parenteral Nutrition (intravenous feeding), as well as other factors operating in the medical nutrition market, such as ingredients and medical devices for nutritional care.
https://www.medicalnutritionindustry.org/
 

Impact of COVID-19 on the global Oncology Nutrition  market 

The COVID-19 pandemic focused attention on the oncology nutrition sector, but healthcare systems were significantly impacted. For example, Nutrition and Cancer published a study in May 2021 that aimed to develop nutritional protocols for the management and prevention of problems during the COVID-19 pandemic for all cancer patients. Patients with cancer are more vulnerable to diseases due to either direct immune system damage or anticancer therapy. Furthermore, according to the article published by the National Library of Medicine in June 2021, the role of nutrition, dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 phase, as well as the value of diet in the susceptibility, prevention, and management of COVID-19 in cancer patients.
The COVID-19 epidemic necessitated the creation of nutritional maintenance and complication control guidelines for all cancer patients, according to the same source. However, the market was gradually stabilising as COVID-19 instances decreased, resulting in a restoration to normal demand levels for oncology nutrition. Thus, COVID-19 is likely to have a substantial impact on the cancer nutrition market throughout the forecast period.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872359/

The oncology nutrition sector is expanding as cancer rates rise, as is demand for food goods in home care settings and enteral nutrition products. Factors driving increase include the transition from parenteral to enteral feeding, rising cancer risk, home healthcare demand, malnutrition treatment, and enhanced medical research on oncology nutrition. Innovative non-GMO formulae and elemental formulations are also driving this increase, thus the future for the oncology nutrition market looks bright.

Frequently Asked Questions (FAQs)